Morgan Lewis partners Shaobin Zhu and Nathan Smith and associate Jensen Xu authored a Life Science Leader article about the amendment to the China Guidance for Patent Examination that took effect on Nov. 1, 2019. In the article, they discussed changes to prosecution in China and key takeaways for medtech companies.